REQUEST A DEMO
Total
USD $0.00
Search more companies

Pharmadesign S.A.S. (Ecuador)

Main Activities: Architectural Services
Full name: Pharmadesign S.A.S. Profile Updated: August 02, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Pharmadesign S.A.S. is based in Ecuador, with the head office in Cuenca. The company operates in the Architectural Services industry. Pharmadesign S.A.S. was incorporated on June 30, 2022. Pharmadesign S.A.S. currently employs 3 (2023) people. There was a net sales revenue increase of 242.2% reported in Pharmadesign S.A.S.’s latest financial highlights for 2023. A growth of 282.83% was recorded in its total assets. The net profit margin of Pharmadesign S.A.S. increased by 24.23% in 2023.

Headquarters
Calle Manuel Vega
Cuenca; Azuay;

Contact Details: Purchase the Pharmadesign S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Pharmadesign S.A.S. report to view the information.
Outstanding Shares:
Purchase the Pharmadesign S.A.S. report to view the information.
Registered Capital:
Purchase the Pharmadesign S.A.S. report to view the information.
Incorporation Date:
June 30, 2022
Key Executives
Purchase this report to view the information.
General Manager
Company Performance
Financial values in the chart are available after Pharmadesign S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
242.2%
Total operating revenue
242.2%
Operating profit (EBIT)
N/A
Net Profit (Loss) for the Period
999.91%
Total assets
282.83%
Total equity
1019.97%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
24.23%
Return on Equity (ROE)
-1.66%
Quick Ratio
5.29%
Cash Ratio
5.29%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?